肿瘤患者-话题@MedSci

#肿瘤患者#

262篇内容 | 5222人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1424314, encodeId=67a81424314db, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=合并巨大甲状腺肿瘤患者急诊腹腔镜胆囊切除手术麻醉选择1例, objectType=article, longId=191993, objectId=1bc0191993db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bc0191993db, replyNumber=0, likeNumber=79, createdTime=2020-04-12, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bc0191993db, moduleTitle=合并巨大甲状腺肿瘤患者急诊腹腔镜胆囊切除手术麻醉选择1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bc0191993db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424313, encodeId=ab95142431376, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=JAMA Oncol：谢丛华教授发现肿瘤患者感染新冠病毒的风险是普通人群的2.31倍, objectType=article, longId=190968, objectId=ecdd1909688a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ecdd1909688a, replyNumber=0, likeNumber=89, createdTime=2020-03-29, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ecdd1909688a, moduleTitle=JAMA Oncol：谢丛华教授发现肿瘤患者感染新冠病毒的风险是普通人群的2.31倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecdd1909688a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424312, encodeId=936b14243121d, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=疫情之下，关注肿瘤患者的治疗与康复, objectType=article, longId=190468, objectId=123f19046869, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=123f19046869, replyNumber=0, likeNumber=88, createdTime=2020-03-22, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=123f19046869, moduleTitle=疫情之下，关注肿瘤患者的治疗与康复, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=123f19046869)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424311, encodeId=fd501424311f3, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=王子平教授：力争防控同时保证肿瘤患者能够有序诊疗，安罗替尼等口服抗肿瘤药物在疫情期间发挥重要作用, objectType=article, longId=189805, objectId=e2d418980531, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2d418980531, replyNumber=0, likeNumber=64, createdTime=2020-03-13, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2d418980531, moduleTitle=王子平教授：力争防控同时保证肿瘤患者能够有序诊疗，安罗替尼等口服抗肿瘤药物在疫情期间发挥重要作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2d418980531)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424310, encodeId=028914243102d, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=以医院登记为基础的20万例恶性肿瘤患者生存报告, objectType=article, longId=189586, objectId=3cff189586dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cff189586dc, replyNumber=0, likeNumber=59, createdTime=2020-03-10, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cff189586dc, moduleTitle=以医院登记为基础的20万例恶性肿瘤患者生存报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cff189586dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424309, encodeId=2a59142430996, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=肺凡力量·疫问医答——百位专家免费义诊，护航肿瘤患者疫情期间生命安全, objectType=article, longId=189277, objectId=7a891892e794, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a891892e794, replyNumber=0, likeNumber=66, createdTime=2020-03-05, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a891892e794, moduleTitle=肺凡力量·疫问医答——百位专家免费义诊，护航肿瘤患者疫情期间生命安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a891892e794)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424308, encodeId=fdcf142430894, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=“氏间有爱，疫情无碍” 罗氏启动公益项目，全力保障肿瘤患者医疗需求, objectType=article, longId=188397, objectId=c1a318839eef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1a318839eef, replyNumber=0, likeNumber=66, createdTime=2020-02-20, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1a318839eef, moduleTitle=“氏间有爱，疫情无碍” 罗氏启动公益项目，全力保障肿瘤患者医疗需求, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1a318839eef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424307, encodeId=5f2b142430e87, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Lancet Haematol：抗胸腺蛋白抗体联合标准GVHD预防疗法可明显改善非亲缘供体移植血液恶性肿瘤患者的预后, objectType=article, longId=187105, objectId=5db718e105b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5db718e105b1, replyNumber=0, likeNumber=86, createdTime=2020-02-03, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5db718e105b1, moduleTitle=Lancet Haematol：抗胸腺蛋白抗体联合标准GVHD预防疗法可明显改善非亲缘供体移植血液恶性肿瘤患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5db718e105b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424306, encodeId=6cad142430640, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=疫情当前，如何为肿瘤患者提供坚实的诊疗保障？, objectType=article, longId=187021, objectId=c6fd18e0213b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6fd18e0213b, replyNumber=0, likeNumber=60, createdTime=2020-02-01, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6fd18e0213b, moduleTitle=疫情当前，如何为肿瘤患者提供坚实的诊疗保障？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6fd18e0213b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424305, encodeId=8d3614243056c, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=JAMA Psychiatry：英国肿瘤患者自杀风险研究, objectType=article, longId=185343, objectId=6d4f185343fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d4f185343fa, replyNumber=0, likeNumber=69, createdTime=2019-12-29, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d4f185343fa, moduleTitle=JAMA Psychiatry：英国肿瘤患者自杀风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d4f185343fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424304, encodeId=b3b9142430433, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Clin Chem：直接基质衍生化联合LC-MS/MS对神经内分泌肿瘤患者富血小板血浆吲哚标记物的定量分析, objectType=article, longId=185129, objectId=a4d518512999, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4d518512999, replyNumber=0, likeNumber=69, createdTime=2019-12-25, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4d518512999, moduleTitle=Clin Chem：直接基质衍生化联合LC-MS/MS对神经内分泌肿瘤患者富血小板血浆吲哚标记物的定量分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4d518512999)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424303, encodeId=cc50142430359, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=女性肿瘤患者依从性管理的现状及思考, objectType=article, longId=184422, objectId=e50e18442234, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e50e18442234, replyNumber=0, likeNumber=74, createdTime=2019-12-09, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e50e18442234, moduleTitle=女性肿瘤患者依从性管理的现状及思考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e50e18442234)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424302, encodeId=6ace14243028c, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=乳腺癌合并甲状腺肿瘤患者，妥妥双靶帮助实现pCR乳腺癌合并甲状腺肿瘤患者，妥妥双靶帮助实现pCR, objectType=article, longId=184349, objectId=6ac01843490f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ac01843490f, replyNumber=0, likeNumber=115, createdTime=2019-12-08, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ac01843490f, moduleTitle=乳腺癌合并甲状腺肿瘤患者，妥妥双靶帮助实现pCR乳腺癌合并甲状腺肿瘤患者，妥妥双靶帮助实现pCR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ac01843490f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424301, encodeId=2ef6142430128, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Stroke：活动性恶性肿瘤患者脑出血后血肿周围水肿特征, objectType=article, longId=183328, objectId=7d89183328d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d89183328d0, replyNumber=0, likeNumber=81, createdTime=2019-11-22, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d89183328d0, moduleTitle=Stroke：活动性恶性肿瘤患者脑出血后血肿周围水肿特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d89183328d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424300, encodeId=61da1424300b0, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=肿瘤患者治疗的“心”思考——合理选择，全程管理, objectType=article, longId=182237, objectId=369c18223ea8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=369c18223ea8, replyNumber=0, likeNumber=54, createdTime=2019-11-03, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=369c18223ea8, moduleTitle=肿瘤患者治疗的“心”思考——合理选择，全程管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=369c18223ea8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424299, encodeId=86e11424299d5, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=拜耳TRK抑制剂Vitrakvi获得欧盟批准治疗NTRK基因融合的肿瘤患者, objectType=article, longId=180106, objectId=b99c180106aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b99c180106aa, replyNumber=0, likeNumber=61, createdTime=2019-09-28, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b99c180106aa, moduleTitle=拜耳TRK抑制剂Vitrakvi获得欧盟批准治疗NTRK基因融合的肿瘤患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b99c180106aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424298, encodeId=391a142429898, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Gastroenterology：磷酸二酯酶5抑制剂的使用与良性结直肠肿瘤患者的结直肠癌风险降低有关, objectType=article, longId=178732, objectId=a09e1e87328e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a09e1e87328e, replyNumber=0, likeNumber=60, createdTime=2019-09-05, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a09e1e87328e, moduleTitle=Gastroenterology：磷酸二酯酶5抑制剂的使用与良性结直肠肿瘤患者的结直肠癌风险降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a09e1e87328e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424297, encodeId=d107142429e76, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=Blood：根据15万+位血液恶性肿瘤患者绘制的家族风险图谱, objectType=article, longId=177660, objectId=255a1e7660c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=255a1e7660c6, replyNumber=0, likeNumber=67, createdTime=2019-08-16, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=255a1e7660c6, moduleTitle=Blood：根据15万+位血液恶性肿瘤患者绘制的家族风险图谱, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=255a1e7660c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424296, encodeId=5da314242968d, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=JCO：生长抑素类似物治疗晚期神经内分泌肿瘤患者的无进展生存期的预测：GETNE-TRASGU研究, objectType=article, longId=177361, objectId=414c1e7361c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=414c1e7361c0, replyNumber=0, likeNumber=64, createdTime=2019-08-11, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=414c1e7361c0, moduleTitle=JCO：生长抑素类似物治疗晚期神经内分泌肿瘤患者的无进展生存期的预测：GETNE-TRASGU研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=414c1e7361c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1424295, encodeId=fccd142429520, content=<a href='/topic/show?id=94c182929d0' target=_blank style='color:#2F92EE;'>#肿瘤患者#</a>, objectTitle=J Cell Biochem：长非编码RNA预测膀胱上皮肿瘤患者生存研究, objectType=article, longId=177232, objectId=5e421e7232f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e421e7232f6, replyNumber=0, likeNumber=62, createdTime=2019-08-10, rootId=0, userName=lanyan20020087, userId=60943920553, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e421e7232f6, moduleTitle=J Cell Biochem：长非编码RNA预测膀胱上皮肿瘤患者生存研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e421e7232f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肿瘤患者

2020-05-29

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

合并巨大甲状腺肿瘤患者急诊腹腔镜胆囊切除手术麻醉选择1例

2020-04-12

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

JAMA Oncol：谢丛华教授发现肿瘤患者感染新冠病毒的风险是普通人群的2.31倍

2020-03-29

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

疫情之下，关注肿瘤患者的治疗与康复

2020-03-22

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

王子平教授：力争防控同时保证肿瘤患者能够有序诊疗，安罗替尼等口服抗肿瘤药物在疫情期间发挥重要作用

2020-03-13

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

以医院登记为基础的20万例恶性肿瘤患者生存报告

2020-03-10

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

肺凡力量·疫问医答——百位专家免费义诊，护航肿瘤患者疫情期间生命安全

2020-03-05

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

“氏间有爱，疫情无碍” 罗氏启动公益项目，全力保障肿瘤患者医疗需求

2020-02-20

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Lancet Haematol：抗胸腺蛋白抗体联合标准GVHD预防疗法可明显改善非亲缘供体移植血液恶性肿瘤患者的预后

2020-02-03

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

疫情当前，如何为肿瘤患者提供坚实的诊疗保障？

2020-02-01

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

JAMA Psychiatry：英国肿瘤患者自杀风险研究

2019-12-29

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Clin Chem：直接基质衍生化联合LC-MS/MS对神经内分泌肿瘤患者富血小板血浆吲哚标记物的定量分析

2019-12-25

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

女性肿瘤患者依从性管理的现状及思考

2019-12-09

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

乳腺癌合并甲状腺肿瘤患者，妥妥双靶帮助实现pCR乳腺癌合并甲状腺肿瘤患者，妥妥双靶帮助实现pCR

2019-12-08

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Stroke：活动性恶性肿瘤患者脑出血后血肿周围水肿特征

2019-11-22

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

肿瘤患者治疗的“心”思考——合理选择，全程管理

2019-11-03

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

拜耳TRK抑制剂Vitrakvi获得欧盟批准治疗NTRK基因融合的肿瘤患者

2019-09-28

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Gastroenterology：磷酸二酯酶5抑制剂的使用与良性结直肠肿瘤患者的结直肠癌风险降低有关

2019-09-05

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

Blood：根据15万+位血液恶性肿瘤患者绘制的家族风险图谱

2019-08-16

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

JCO：生长抑素类似物治疗晚期神经内分泌肿瘤患者的无进展生存期的预测：GETNE-TRASGU研究

2019-08-11

lanyan20020087 (审核中...)

前往app查看评论内容

#肿瘤患者#

J Cell Biochem：长非编码RNA预测膀胱上皮肿瘤患者生存研究

2019-08-10

科室
- - 订阅+
  - 更多科室
工具
服务